These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 558266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G, Vermylen J, Donati MB, Van Damme B, Michielsen P.
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract] [Full Text] [Related]

  • 3. [ Products of fibrin degradation in the urine during experimental and human glomerulonephritis].
    Lagrue G, Hirbec G, Gouault-Heilmann M, Levent M, Branellec A, Moisy M.
    Pathol Biol (Paris); 1975 Jun; 23(6):486-91. PubMed ID: 1105353
    [Abstract] [Full Text] [Related]

  • 4. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T, Sumie A, Ishii T, Tomo T, Magari Y, Sato J, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [Abstract] [Full Text] [Related]

  • 5. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE, Cajthamlová H, Suttnar J.
    Cas Lek Cesk; 1990 Oct 26; 129(43):1349-51. PubMed ID: 2249231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP.
    N Z Med J; 1977 Oct 12; 86(597):332-4. PubMed ID: 272538
    [Abstract] [Full Text] [Related]

  • 8. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML, Bang NU.
    J Lab Clin Med; 1977 Jul 12; 90(1):216-26. PubMed ID: 874368
    [Abstract] [Full Text] [Related]

  • 9. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.
    Hall CL, Blainey JD, Gaffney PJ.
    Nephron; 1979 Jul 12; 23(1):6-9. PubMed ID: 450168
    [Abstract] [Full Text] [Related]

  • 10. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun 12; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 11. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S, Ideura T, Ida T, Osaka Y, Kuriyama R, Abe T, Takeuchi J.
    Clin Nephrol; 1979 Dec 12; 12(6):248-53. PubMed ID: 527278
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD, Terry JM.
    Clin Nephrol; 1979 Mar 12; 11(3):140-1. PubMed ID: 436342
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M, Oetliker O, Montandon A, Beck EA.
    Schweiz Med Wochenschr; 1975 Aug 16; 105(33):1040-7. PubMed ID: 1099647
    [Abstract] [Full Text] [Related]

  • 15. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
    Silva FG, Hoyer JR, Pirani CL.
    Lab Invest; 1984 Oct 16; 51(4):404-15. PubMed ID: 6434880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary fibrin split products in lupus nephritis.
    Zizic TM, Cwazka WF, Young NS, Stevens MB.
    J Rheumatol; 1976 Mar 16; 3(1):43-9. PubMed ID: 775087
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K, Matsunaga T, Kawahara S, Sakamoto S, Kamitsuji H.
    Thromb Res; 1989 Feb 15; 53(4):367-77. PubMed ID: 2929008
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S, Wadhwa NK, Kant KS, Pollak VE, Glas-Greenwalt P, Weiss MA, Hong CG.
    Q J Med; 1988 Nov 15; 69(259):879-905. PubMed ID: 3078212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.